Melissa Berrien-Elliott

Has grant

Assistant Professor

Saint Louis University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Melissa Berrien-Elliott is an Assistant Professor at Saint Louis University in the United States. Her research focuses on innovative therapies using natural killer (NK) cells for cancer treatment, including allogeneic cell therapy and adoptive immunotherapy. Recent articles highlight her work on memory-like NK cells, their role in relapsed leukemia, and the potential of combining antibody therapies with NK cell treatments.

Recent Grants

Grant: Close

Mechanisms underlying cytokine-induced memory-like natural killer cell differentiation and maintenance.

Open Date: 2015-07-01

Close Date: 2018-06-30

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

UNITED STATES

View details

Miriam Jacobs

Georgetown University

UNITED STATES

View details

Nancy Dora Marin Agudelo

Washington University in St. Louis

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Melissa Berrien-Elliott

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Allogeneic natural killer cell therapy

Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy

Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia

Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant

Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma

Memory-like Differentiation Enhances NK Cell Responses to Melanoma

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma

Memory-like natural killer cells for cancer immunotherapy

Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia

Collaborators (7)

Todd A. Fehniger

Kilannin Krysiak

Jeffrey Ward

Jeffrey Bednarski

David A. Russler-Germain

Miriam Jacobs

Nancy Dora Marin Agudelo

Make your next move.